2020
Evaluation of Daratumumab for the Treatment of Multiple Myeloma in Patients With High-risk Cytogenetic Factors
Giri S, Grimshaw A, Bal S, Godby K, Kharel P, Djulbegovic B, Dimopoulos MA, Facon T, Usmani SZ, Mateos MV, Costa LJ. Evaluation of Daratumumab for the Treatment of Multiple Myeloma in Patients With High-risk Cytogenetic Factors. JAMA Oncology 2020, 6: 1759-1765. PMID: 32970151, PMCID: PMC7516804, DOI: 10.1001/jamaoncol.2020.4338.Peer-Reviewed Original ResearchConceptsProgression-free survivalHigh-risk MMBackbone regimensRefractory MMHazard ratioMultiple myelomaClinical trialsSystematic reviewDerSimonian-Laird random-effects modelPhase 3 trialImproved response ratesPreferred Reporting ItemsRandom-effects modelCochrane riskSame regimenCytogenetic riskCochrane LibraryMeeting libraryI2 statisticImproved outcomesMAIN OUTCOMEThird investigatorCochran's QPatientsReporting Items
2019
The application of appropriate use criteria for transthoracic echocardiography in a cardiac intensive care unit
Salik JR, Sen S, Picard MH, Weiner RB, Dudzinski DM. The application of appropriate use criteria for transthoracic echocardiography in a cardiac intensive care unit. Echocardiography 2019, 36: 631-638. PMID: 30969477, DOI: 10.1111/echo.14314.Peer-Reviewed Original ResearchConceptsCardiac intensive care unitCurrent appropriate use criteriaAppropriate use criteriaIntensive care unitCare unitModern cardiac intensive care unitUse criteriaQuaternary care academic medical centerUnique clinical environmentAcademic medical centerTransthoracic echocardiographyCardiac arrestUnknown etiologyMedical CenterThird investigatorCardiac structureHealthcare resourcesAUC classificationClinical casesInitial evaluationTTEFurther studiesClinical environmentInvestigatorsIndications
2016
Corticosteroids Versus Pentoxifylline for Severe Alcoholic Hepatitis
Njei B, Do A, McCarty TR, Fortune BE. Corticosteroids Versus Pentoxifylline for Severe Alcoholic Hepatitis. Journal Of Clinical Gastroenterology 2016, 50: 871-881. PMID: 27404293, PMCID: PMC5065367, DOI: 10.1097/mcg.0000000000000585.Peer-Reviewed Original ResearchConceptsSevere alcoholic hepatitisAlcoholic hepatitisTrial sequential analysisShort-term mortalityHepatorenal syndromeStudies satisfied inclusion criteriaEffect of corticosteroidsSatisfied inclusion criteriaMortality benefitSignificant morbidityCochrane CollaborationEpidemiologic evidenceCochrane LibraryInclusion criteriaCorticosteroidsHepatitisIndependent reviewersTherapeutic strategiesThird investigatorPentoxifyllinePublication statusPlaceboComprehensive searchMortalityInitial reviewers
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply